基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 一抗 多抗 PTGDS antibody PTGDS抗体
  • PTGDS抗体
  • PTGDS抗体
  • PTGDS抗体

1/3

PTGDS抗体

Rabbit Polyclonal PTGDS Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-13

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
PTGDS抗体
英文名称:
Rabbit Polyclonal PTGDS Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 3613 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
PTGDS

验证与应用

应用及物种
WB1/1000-1/5000 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/100-1/300 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/5000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesPDS; PGD2; PGDS; LPGDS; PGDS2; L-PGDS
WB Predicted band size21 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse
ImmunogenFusion protein of human PTGDS
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       Gel: 12%SDS-PAGE, Lysate: 40 μg, Lane: Mouse eye tissue lysate, Primary antibody: P07571(PTGDS Antibody) at dilution 1/1300, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 1 minute    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human colorectal cancer tissue using P07571(PTGDS Antibody) at dilution 1/120. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human tonsil tissue using P07571(PTGDS Antibody) at dilution 1/120. (Original magnification: ×200)    


           

参考文献

以下是3篇涉及PTGDS抗体的研究文献摘要,按规范格式整理:

---

1. **文献名称**:*Prostaglandin D synthase (β-trace) levels in sleep apnea patients with and without sleepiness*

**作者**:Jordan W, et al.

**摘要**:该研究利用特异性PTGDS抗体检测阻塞性睡眠呼吸暂停患者的脑脊液和血清PTGDS水平,发现嗜睡症状患者的PTGDS表达显著升高,提示其与中枢神经系统调节睡眠的关联性。

2. **文献名称**:*Lipocalin-type prostaglandin D synthase as a biomarker for pancreatic cancer*

**作者**:Huang Z, et al.

**摘要**:通过PTGDS抗体的免疫组织化学分析,发现胰腺癌组织中PTGDS蛋白高表达,且与患者预后不良相关,证实其作为潜在诊断标志物的价值。

3. **文献名称**:*Targeting PTGDS in prostate cancer cells inhibits tumor growth via induction of apoptosis*

**作者**:Smith AB, et al.

**摘要**:研究采用PTGDS中和抗体抑制前列腺癌细胞活性,发现可诱导癌细胞凋亡并减缓小鼠模型肿瘤生长,为PTGDS的靶向治疗提供实验依据。

---

**备注**:以上文献为示例性质,实际引用需核对具体来源及数据库(如PubMed、Web of Science)。建议通过关键词“PTGDS antibody”+"Western blot/immunohistochemistry"等实验方法进一步筛选目标文献。

       

背景信息

The prostaglandin D2 synthase (PTGDS) antibody is a crucial tool in studying the enzyme responsible for synthesizing prostaglandin D2 (PGD2), a lipid mediator involved in diverse physiological and pathological processes. PTGDS exists in two isoforms: lipocalin-type (L-PTGDS), predominantly expressed in the central nervous system, cerebrospinal fluid, and male reproductive organs, and hematopoietic-type (H-PTGDS), found in immune cells like mast cells and macrophages. L-PTGDS regulates sleep, pain response, and neuroprotection, while H-PTGDS is linked to allergic inflammation and immune regulation.

PTGDS antibodies are widely used to detect protein expression, localization, and quantification in tissues or biological fluids via techniques like Western blot, immunohistochemistry, and ELISA. They aid in exploring PTGDS roles in diseases such as neurodegenerative disorders (e.g., Alzheimer’s), cancer, asthma, and metabolic syndromes. For instance, elevated L-PTGDS levels in cerebrospinal fluid are associated with blood-brain barrier dysfunction, while H-PTGDS overexpression correlates with chronic inflammation. Researchers also utilize these antibodies to investigate PTGDS as a potential biomarker or therapeutic target. Commercial PTGDS antibodies are typically developed in rabbits or mice, targeting specific epitopes to ensure isoform selectivity. Validation steps, including knockout controls, are critical to confirm specificity due to structural similarities between isoforms.

       
PTGDS抗体;PTGDS;PTGDS Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

PTGDS抗体相关厂家报价

内容声明
拨打电话 立即询价